Impostor syndrome makes us doubt our success and fear being exposed as frauds. Rooted in past experiences, it fuels anxiety, but therapy can help build true self-worth.

When healthcare providers dismiss symptoms, it can cause lasting harm. A new study reveals how such invalidation affects ...

Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...

Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy- Globally, this is the first bispecific CD19-directed CD3 T cell engager immunotherapy for this autoimmune ...

Discover musculoskeletal disorder symptoms affecting bones, muscles, joints, and tendons. Learn causes, treatments, and ...

Stevens-Johnson syndrome and its more severe variant, toxic epidermal necrolysis, are rare and dangerous immunologic diseases ...

When we applied to HGSE, each of us wrote a personal statement — a story about who we were, what we believed in, and what ...

An analysis of a large national database shows a diagnosis of bipolar disorder or major depressive disorder is linked to an ...

The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.

We understand the importance of consistent quality sleep for health, but did you know research confirms that rest-disrupting ...

Eton Pharmaceuticals, Inc (“Eton” or“the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the U.S.

KHINDIVI is the first and only FDA-approved hydrocortisone oral solution• Commercial launch expected the week of June 2nd• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocort ...